Latest Distributions News

Pure Foods Tasmania has reported a profitable quarter with improved margins and strategic growth moves, including a new contract packing deal and the acquisition of premium ice cream brand Elato.

First Au Limited reports promising gold assay results at its Nimba project in Liberia, while strategically divesting its Victorian Goldfield Project to focus on Western Australian assets.

Activeport Group Ltd reported steady Q2 FY26 revenue with new contracts starting to contribute and a 5% increase in annualised recurring revenue to $6.3 million. The company also reduced cash burn significantly and strengthened its cash position to support growth.

Nuchev Limited reported a 19% decline in Q2 FY26 sales revenue, with steady retail performance in its Oli6® brand offset by a sharp drop in the Practitioner channel. The company remains debt-free and is advancing new product development to drive future growth.

Next Science Limited has updated the payment date for its cash return of capital to 10 February 2026, following its recent asset sale and pending ASX delisting.

Merino & Co. reported steady progress in Q2 FY26 with growing demand from China and ongoing investments in brand and manufacturing, despite a tightening cash position.

GreenHy2 Limited has reported its first revenue from sodium-ion battery sales alongside a robust $2 million residential sales pipeline, while advancing strategic partnerships and certification efforts to accelerate market adoption.

EVE Health Group has transitioned from development to commercial rollout, delivering first patient prescriptions of Dyspro™ and completing initial manufacturing of Libbo™, supported by a $1.1 million capital raise.

Oakridge International reports solid growth in healthcare technology revenues and product development progress, while navigating a potential legal claim from Teko International.

H3 Energy Limited has made significant technical progress in de-risking its Warro Gas Field and confirmed the presence of natural hydrogen at the Rickerscote Prospect, while appointing a new CEO and completing a corporate rebrand.

Qualitas Real Estate Income Fund has concluded its recent rights issue without issuing any shortfall units, a move it says benefits unitholders. The decision finalises the capital raising process initiated in November 2025.

Tissue Repair’s December quarter update reveals a cautious path forward for its Phase 3 TR987 trial amid slow patient recruitment, while its TR Pro+ product line gains momentum through a new distributor partnership and upcoming product launches.